Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

The questionable resume, and relaxed timeline of Sjögren's hiring leave more questions than answers around Stars' future ...

Martin Sjögren will join the Chicago Stars in January as their new coach. Anders Jacobson, Sjögren’s first assistant, will ...

The Chicago Stars have named former Norway women’s national team coach Martin Sjögren as the National Women’s Soccer League ...

Sjögren, who currently is head coach of Hammarby in the Swedish Damallsvenskan league, will join the Stars for the start of ...

Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands ...

The NWSL’s Chicago Stars have named Martin Sjögren as the club’s new head coach, the club announced Wednesday. Sjögren, who ...

The Chicago Stars have hired former Norway women's national team head coach Martin Sjögren for the same role, the NWSL club ...

Adults with Sjögren’s disease complicated by a subtype of cutaneous vasculitis are more likely to develop non-Hodgkin’s ...

Phase 3 results position telitacicept as potential best-in-disease profile in primary Sjögren's disease Telitacicept ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

Primary Sjögren’s syndrome is a common systemic autoimmune disease, with a female-to-male predominance of 9:1 and peak incidence at approximately 50 years of age. 1 The hallmark of the disease ...